| |
|
2005 - Full-Text and Abstracts
|
|
Top
|
|
Vol. 35
|
|
October October 2005 No. 4, p213
|
|
Head and Neck Disease
|
|
July July 2005 No. 3, p159
|
|
Lymphoma
|
|
April April 2005 No. 2, p83
|
|
Breast Disease
|
|
January January 2005 No. 1, p1
|
|
Cardiovascular Nuclear Medicine
|
|
|
2004 - Full-Text and Abstracts
|
|
Top
|
|
Vol. 34
|
|
October October 2004 No. 4, p241
|
|
Positron Emission Tomography, Part III
|
|
July July 2004 No. 3, p165
|
|
Positron Emission Tomography, Part II
|
|
April April 2004 No. 2, p83
|
|
January, Supplement January 2004 No. 1, p1
|
|
January January 2004 No. 1, p1
|
|
Molecular Imaging in Nuclear Medicine
|
|
|
2003 - Full-Text and Abstracts as of April 2003
|
|
Top
|
|
Vol. 33
|
|
October October 2003 No. 4, p245
|
|
Emergency Nuclear Medicine Procedures
|
|
July July 2003 No. 3, p163
|
|
April April 2003 No. 2, p87
|
|
January January 2003 No. 1, p1
|
|
Functional Brain Imaging (Part I)
|
|
|
2002 - Abstracts and References
|
|
Top
|
|
Vol. 32
|
|
October October 2002 No. 4, p239
|
|
July July 2002 No. 3, p157
|
|
April April 2002 No. 2, p77
|
|
Radiolabeled Peptides in Diagnoses and Therapy
|
|
January January 2002 No. 1, p1
|
|
Impact of FDG-PET Imaging on the Practice of Medicine
|
|
|
2001
|
|
Top
|
|
Vol. 31
|
|
October October 2001 No. 4, p255
|
|
Radiochemistry update
|
|
July July 2001 No. 3, p171
|
|
Monitoring Therapeutic Interventions with Nuclear Medicine
|
|
April April 2001 No. 2, p87
|
|
Vascular and Thromboembolic Disease
|
|
January January 2001 No. 1, p1
|
|
Recent Developments in Skeletal Scintigraphy
|
|
| |
|
|
